fred...you are welcome...this just out..around $4+ om Naz
(PR NEWSWIRE) Commonwealth Biotechnologies, Inc. Active in War Against Bio Te
Commonwealth Biotechnologies, Inc. Active in War Against Bio Terrorism
Company is National Leader in Analysis of Pathogenic Organisms and Toxins
RICHMOND, Va., Sept. 20 /PRNewswire/ -- For the past three years,
Commonwealth Biotechnologies, Inc. (Nasdaq: CBTE), a life science's contract
research organization, has worked under different government contracts to
develop and implement novel methods for detection and analysis of human
pathogenic organisms and toxins which could conceivably be used in a bio-
terrorist attack. The horrific events of September 11 have made Americans
acutely aware of real and perceived terrorist threats to our National safety.
"Few people realize the complexities involved in trying to confirm the
presence of pathogenic organisms in environmental matrices," said Dr. Robert
B. Harris, President of CBI and Scientific Director for most of the on-going
studies. "CBI is well positioned to do this work because we can apply CBI's
collective expertise in the areas of bioorganic chemistry, mass spectroscopy,
microbiology and molecular biology and so forth to addressing the goals of the
research problems.
The research contracts under which CBI operates to meet these objectives
collectively bring over $ 2 million into the Company on an annual basis. Each
of the contracts can be renewed annually at the discretion of the individual
sponsors for periods up to 5 years. CBI just recently signed two new multiple
year contracts which extend the Company's work in protocol development. Due
to confidentiality issues, details of the new contracts cannot be made
available.
"The sponsors of these research programs acknowledge CBI's expertise in
the field and recognize the importance of continuing fundamental work in the
area of identifying molecular analytes in environmental samples", said Tom
Reynolds, Senior Vice President of CBI. "CBI is one of only a few select
companies which can undertake these research programs," added Reynolds, "and
is widely recognized for its leadership role in designing, implementing, and
testing novel detection protocols for the presence of pathogenic organisms and
toxins."
Harris concludes, "Speaking on behalf of our industry, we stand ready to
help in any way possible to minimize very real threats to our collective
future."
Founded in 1992, CBI is located at 601 Biotech Drive, Richmond, VA 23235
(1-800-735-9224). The company occupied its 32,000 square foot facility in
December 1998 and currently employs a staff of about 40, including twelve
doctoral scientists. CBI has provided comprehensive research and development
services to more than 2,000 private, government, and academic customers in the
global biotechnology industry. For more information, visit CBI on the web at
cbi-biotech.com .
Any statements contained in this release that relate to future plans,
events or performance are forward-looking statements that involve risks and
uncertainties as identified in the Company's filings with the Securities and
Exchange Commission. Actual results, events or performance may differ
materially. Readers are cautioned not to place undo reliance on these forward-
looking statements, which speak only as the date hereof. The companies
undertake no obligation to publicly release the results of any revisions to
these forward looking statements that may be made to reflect the events or
circumstances after the date hereof or to reflect the occurrence of
unanticipated events.
MAKE YOUR OPINION COUNT - Click Here
tbutton.prnewswire.com
SOURCE Commonwealth Biotechnologies, Inc.
-0- 09/20/2001
/CONTACT: William S. Ballas, +1-804-278-9901, or ballas1@erols.com, for
Commonwealth Biotechnologies, Inc./
/Web site: cbi-biotech.com
(CBTE)
CO: Commonwealth Biotechnologies, Inc.
ST: Virginia
IN: BIO MTC ARO
SU:
*** end of story *** |
